SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150
Antonio Barbáchano(Consejo Superior de Investigaciones Científicas), Alberto Múñoz(Consejo Superior de Investigaciones Científicas), Miguel F. Segura(Universitat Autònoma de Barcelona), Alba Costales‐Carrera(Consejo Superior de Investigaciones Científicas), Douglas Hanniford(New York University), Francisco X. Real(Universitat Pompeu Fabra), Paloma Ordóñez‐Morán(University of Nottingham), José M. Rojas(Universidad de Antofagasta), Nerea Martı́nez(Instituto de Salud Carlos III), José Manuel González‐Sancho(Consejo Superior de Investigaciones Científicas), Asunción Fernández‐Barral(Universidad Autónoma de Madrid), Héctor G. Pálmer(CIBBIM-Nanomedicine), Enrique Carrillo de Santa Pau(Madrid Institute for Advanced Studies), Fábio Pereira(Universidade Federal de Alfenas), Eva Hernando(Eastern Cooperative Oncology Group)
Cited by 48
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
|The Lancet|2005|631
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment
|Frontiers in Microbiology|2021|390
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386